XORTX Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -28 | -25 | -25 | |
EBITDA | -862 | -937 | 144 | -848 |
EBIT | -889 | -963 | 119 | -874 |
Net Income | -717 | -698 | 119 | -587 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -815 | -647 | -865 | -775 |
Cash | 1,063 | 1,895 | 2,472 | 2,300 |
Basic Shares | 3,788 | 3,737 | 3,063 | 2,903 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -141 | -75 | -17 | |
EBITDA | -3,706 | -4,870 | -9,410 | -1,628 |
EBIT | -3,762 | -5,012 | -9,485 | -1,646 |
Net Income | -4,763 | -2,152 | -6,988 | -1,295 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,717 | -6,629 | -8,862 | -4,786 |
Cash | 2,473 | 3,447 | 10,407 | 14,785 |
Basic Shares | 2,878 | 1,981 | 1,479 | 1,090 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.19 |
2025-03-31 | $0.04 |
2024-12-31 | -$0.81 |
2024-09-30 | -$0.20 |
